Your new post is loading...
getty An innovative immunotherapy combination has shown a stunning 99% response rate in children with relapsed leukemia. The phase 2 trial, run jointly between researchers at St. Jude Children’s Re…
|
Scooped by Online Marketing |
Scoop.it!
No comment yet.
Sign up to comment
